SCHEMBL6095875

SCHEMBL6095875

CCc1[nH]c2ccccc2c1C1=C(O)C(=O)C=C(O)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 2/20 0.41
KDM4E B2RXH2 8/20 0.40
NPEPPS P55786 1/20 0.39
RAB9A P51151 3/20 0.38
HPGD P15428 4/20 0.37
ALDH1A1 P00352 3/20 0.37
POLB P06746 2/20 0.37
HTT P42858 1/20 0.37
CCR6 P51684 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
HSD17B10 Q99714 2/20 0.36
USP2 O75604 1/20 0.36
DAO P14920 2/20 0.35
DDO Q99489 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
G6PD P11413 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6252288 0.86 NPEPPS (0.43) KDM4ENPEPPSRAB9AHPGDALDH1A1
SCHEMBL8601530 0.84 MEN1 (0.39) XIAPKDM4ERAB9AHPGDALDH1A1
SCHEMBL6110147 0.83 CCR6 (0.51) KDM4ERAB9AHPGDALDH1A1HTT
SCHEMBL6093878 0.80 PTPRC (0.54) KDM4EHPGDALDH1A1TDP1MEN1
SCHEMBL6096689 0.80 HPGD (0.40) XIAPKDM4ERAB9AHPGDALDH1A1
SCHEMBL6094612 0.80 KDM4E (0.40) KDM4ERAB9AHPGDALDH1A1POLB
SCHEMBL6096623 0.78 ALDH1A1 (0.39) KDM4ERAB9AHPGDALDH1A1POLB
SCHEMBL6094828 0.76 NPC1 (0.38) KDM4ERAB9AHPGDALDH1A1POLB
SCHEMBL6257929 0.76 KDM4E (0.50) KDM4ENPEPPSRAB9AHPGDALDH1A1
SCHEMBL6095918 0.75 TSHR (0.38) KDM4ERAB9AHPGDALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA XIAP 620/4885KDM4E 2246/4885NPEPPS 1256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.